[Tyr4] - MBP (1 - 11)
CAS No. ———
[Tyr4] - MBP (1 - 11)( ——— )
Catalog No. M41370 CAS No. ———
[Tyr4] - MBP (1 - 11)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name[Tyr4] - MBP (1 - 11)
-
NoteResearch use only, not for human use.
-
Brief Description[Tyr4] - MBP (1 - 11)
-
Description[Tyr4] - MBP (1 - 11)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight1328.42
-
Molecular FormulaC55H85N21O18
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Semax acetate(80714-...
Semax acetate is a synthetic peptide analog of adrenocorticotropic hormone (ACTH) that has neuroprotective, analgesic, and anxiolytic properties.
-
Frovocimab
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia.
-
BT44
BT44 is a novel, second-generation glial cell linederived neurotropic factor mimetic with improved biological activity and is a lead compound for the treatment of neurodegenerative disorders.
Cart
sales@molnova.com